Defense Health Agency Contracting Activity - DHACA
· Federal agency
DoD Prostate Cancer, Health Disparity Research Award
The Health Disparity Research Award supports promising research ideas that have high potential to make a significant impact in eliminating disparities in prostate cancer survivorship. Definitions of Health Disparity: The...
61
match
Deadline2529 days agoLocationAlabamaTypegrantLevelFederalClosedposted May 3, 2019
✦ AI Summary
Who can apply: Federal-level applicants (see eligibility for details).
Funding amount: total funding pool ~$9,840,000.
Next deadline: July 18, 2019.
Issued by: Defense Health Agency Contracting Activity - DHACA.
The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.
AI-generated. Always verify with the official source.
Deadline
2529 days ago
Jul 18, 2019
Total pool
$9.8M
About this opportunity
The Health Disparity Research Award supports promising research ideas that have high potential to make a significant impact in eliminating disparities in prostate cancer survivorship. Definitions of Health Disparity: The PCRP is interested in research that addresses all different aspects that contribute to health disparity in prostate not limited to: • Access to health care, which may stem from geographic location, socioeconomic status, or other factors. • Social and cultural factors that may influence patient decisions related to screening and treatment. This could include the role of social/support networks, community influence, cultural or religious practices, psychological health, etc. • Environmental factors that may cause endogenous changes, such as environmental exposures, dietary factors, and other external factors that may contribute to prostate cancer disparities in specific populations. • Biological contributors, such as genetic differences, that can be associated with disparate outcomes in patient populations. It is the responsibility of the applicant to clearly and explicitly describe the area of health disparity that the research proposal aims to address. Community Engagement: Investigators are highly encouraged to engage members of the targeted population or community in the development and implementation of their research project, where appropriate. A comprehensive, but by no means exhaustive, list of health disparity research resources and community or advocacy organizations is provided at the end of the HDRA Award Information section. Applications that involve and utilize population- or community-based organizations to support their research project should demonstrate the level of involvement in letters of support for the application. Impact: Research supported by the Health Disparity Research Award is expected to have the potential to make a significant impact in addressing prostate cancer health disparities. Research with a high degree of innovation is anticipated to have a higher potential for significant impact. Applications must also include a detailed transition plan that articulates the pathway to moving the project’s findings to the next phase of development after successful completion of the award, and continue advancing the research toward making a clinical impact, even if clinical impact is not an immediate outcome. Research Scope: Proposed projects may include clinical research, including clinical trials. Investigators from a spectrum of disciplines, including but not limited to basic research, health care services, and clinical research, are encouraged to submit applications, provided they are appropriately focused on an issue of prostate cancer health disparity. Only small-scale, early ( up to and including Phase II or equivalent) clinical trials are allowed. Investigators proposing a clinical trial are highly encouraged to consider leveraging the PCRP Prostate Cancer Clinical Trials Consortium (PCCTC) (http://pcctc.org/) to facilitate the rapid initiation and completion of the trial. The inclusion of preliminary data is encouraged but not required. Any preliminary, unpublished data provided should be from the Principal Investigator (PI) or a member(s) of the research team. New FY19 definition: A clinical trial is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. To maximize the potential for impact, investigators are strongly encouraged to incorporate the following components into their study design where appropriate: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; incorporation of experiments to assess clinical relevance and translatability of findings.
Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.
Need help getting in touch with the right agency contact?
Create a free account and our specialists will guide you through the application end-to-end.